Explore Watchlists Pricing

VERTEX PHARMACEUTICALS INC (VRTX) Income statement

Market cap

$111.4B

P/E ratio

28.6x

Summary Financials

Income statement Balance sheet Cash flow Other

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Revenue	143	1,411	1,527	1,212	580	1,032	1,702	2,489	3,048	4,163	6,206	7,574	8,931	9,869	11,020	12,001
Revenue growth (%)	-
Cost of revenue	-	64	237	89	40	117	207	273	410	548	736	904	1,080	1,262	1,531	1,651
Research & development	637	708	806	919	856	996	1,048	1,325	1,416	1,755	1,830	3,051	-	-	-	-
Selling, general & administrative	188	401	437	362	305	377	433	496	558	658	770	840	945	1,137	1,464	1,753
Operating margin (%)
Operating expenses	839	1,297	1,525	2,115	1,273	1,499	1,692	2,365	2,412	2,965	3,349	4,792	4,623	6,037	11,253	7,828
Operating income	-696	114	2	-903	-692	-467	10	123	635	1,198	2,856	2,782	4,307	3,832	-233	4,173
Income before tax	-	60	-12	-976	-735	-558	-67	-16	600	1,395	3,117	2,730	4,232	4,380	249	4,643
Pretax margin (%)	-	4.3	-0.8	-80.5	-126.6	-54	-4	-0.6	19.7	33.5	50.2	36	47.4	44.4	2.3	38.7
Provision for income taxes	-	19	39	-289	7	30	17	-107	-1,487	218	405	388	910	760	784	690
Effective tax rate (%)	-
Net income	-755	41	-51	-445	-739	-556	-84	263	2,097	1,177	2,712	2,342	3,322	3,620	-536	3,953
Net income margin (%)
Earnings per share	-3.77	0.14	-0.5	-1.98	-3.14	-2.31	-0.46	1.06	8.24	4.58	10.44	9.09	12.97	14.05	-2.08	15.46
Diluted EPS	-3.77	0.14	-0.5	-1.98	-3.14	-2.31	-0.46	1.04	8.09	4.51	10.29	9.01	12.82	13.89	-2.08	15.32
EBITDA
EBITDA margin (%)